Cargando…

Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis

OBJECTIVES: Our aim was to identify the impact of psychosocial predictors, specifically relationship style, depressive symptoms, anxiety symptoms, cognitive impairment, and culture-specific disease beliefs, on treatment adherence for multiple sclerosis (MS) patients. METHODS: In this cross-sectional...

Descripción completa

Detalles Bibliográficos
Autores principales: Alosaimi, Fahad D, AlMulhem, Alaa, AlShalan, Hanan, Alqazlan, Mohammad, Aldaif, Abdulgader, Kowgier, Matthew, Balasundaram, Janooshsheya, Sockalingam, Sanjeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352251/
https://www.ncbi.nlm.nih.gov/pubmed/28331298
http://dx.doi.org/10.2147/PPA.S129678
_version_ 1782514920700510208
author Alosaimi, Fahad D
AlMulhem, Alaa
AlShalan, Hanan
Alqazlan, Mohammad
Aldaif, Abdulgader
Kowgier, Matthew
Balasundaram, Janooshsheya
Sockalingam, Sanjeev
author_facet Alosaimi, Fahad D
AlMulhem, Alaa
AlShalan, Hanan
Alqazlan, Mohammad
Aldaif, Abdulgader
Kowgier, Matthew
Balasundaram, Janooshsheya
Sockalingam, Sanjeev
author_sort Alosaimi, Fahad D
collection PubMed
description OBJECTIVES: Our aim was to identify the impact of psychosocial predictors, specifically relationship style, depressive symptoms, anxiety symptoms, cognitive impairment, and culture-specific disease beliefs, on treatment adherence for multiple sclerosis (MS) patients. METHODS: In this cross-sectional observational study, patients from two MS clinics in Saudi Arabia completed self-reported questionnaires focused on MS treatment adherence, physical symptom burden, relationship style, cultural beliefs, depressive symptoms, anxiety, and cognitive impairment. RESULTS: A total of 163 MS patients participated, 81.6% of them were female, and the mean age of the patients was 31.6 years. Mean patient-reported adherence to their MS treatment regimen was 79.47%±25.26%. Multivariate linear regression analysis only identified patients’ belief that their MS was due to “supernatural” forces as being significantly negatively associated with MS medication adherence. CONCLUSION: This study demonstrates the importance of cultural interpretations to MS medication adherence in comparison to psychosocial factors. Education and family involvement in the treatment planning may address this issue and warrant further research.
format Online
Article
Text
id pubmed-5352251
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53522512017-03-22 Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis Alosaimi, Fahad D AlMulhem, Alaa AlShalan, Hanan Alqazlan, Mohammad Aldaif, Abdulgader Kowgier, Matthew Balasundaram, Janooshsheya Sockalingam, Sanjeev Patient Prefer Adherence Original Research OBJECTIVES: Our aim was to identify the impact of psychosocial predictors, specifically relationship style, depressive symptoms, anxiety symptoms, cognitive impairment, and culture-specific disease beliefs, on treatment adherence for multiple sclerosis (MS) patients. METHODS: In this cross-sectional observational study, patients from two MS clinics in Saudi Arabia completed self-reported questionnaires focused on MS treatment adherence, physical symptom burden, relationship style, cultural beliefs, depressive symptoms, anxiety, and cognitive impairment. RESULTS: A total of 163 MS patients participated, 81.6% of them were female, and the mean age of the patients was 31.6 years. Mean patient-reported adherence to their MS treatment regimen was 79.47%±25.26%. Multivariate linear regression analysis only identified patients’ belief that their MS was due to “supernatural” forces as being significantly negatively associated with MS medication adherence. CONCLUSION: This study demonstrates the importance of cultural interpretations to MS medication adherence in comparison to psychosocial factors. Education and family involvement in the treatment planning may address this issue and warrant further research. Dove Medical Press 2017-03-09 /pmc/articles/PMC5352251/ /pubmed/28331298 http://dx.doi.org/10.2147/PPA.S129678 Text en © 2017 Alosaimi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Alosaimi, Fahad D
AlMulhem, Alaa
AlShalan, Hanan
Alqazlan, Mohammad
Aldaif, Abdulgader
Kowgier, Matthew
Balasundaram, Janooshsheya
Sockalingam, Sanjeev
Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
title Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
title_full Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
title_fullStr Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
title_full_unstemmed Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
title_short Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
title_sort psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352251/
https://www.ncbi.nlm.nih.gov/pubmed/28331298
http://dx.doi.org/10.2147/PPA.S129678
work_keys_str_mv AT alosaimifahadd psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis
AT almulhemalaa psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis
AT alshalanhanan psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis
AT alqazlanmohammad psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis
AT aldaifabdulgader psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis
AT kowgiermatthew psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis
AT balasundaramjanooshsheya psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis
AT sockalingamsanjeev psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis